Literature DB >> 18290809

DNase test as a novel approach for the routine screening of Corynebacterium diphtheriae.

F P Pimenta1, M C Souza, G A Pereira, R Hirata, T C F Camello, A L Mattos-Guaraldi.   

Abstract

AIMS: To examine the value of the DNase test as an alternative procedure for differentiating Corynebacterium diphtheriae from Corynebacterium-like colonies. METHODS AND
RESULTS: DNase test medium was inoculated by spotting a loopful of bacterial growth and incubated aerobically at 37 degrees C. The DNase production was detectable following both 24 and 48 h incubation periods. The DNase activity was detected in all 91 C. diphtheriae (37 toxigenic and 54 nontoxigenic) strains examined, previously identified by both conventional biochemical methods and API Coryne System. Conversely, DNase test results were negative in 93.9% of the 564 nondiphtherial Gram-positive rod clinical strains.
CONCLUSIONS: The DNase test emerged as an easily interpretable and cost-effective alternative screening procedure for C. diphtheriae laboratory identification. SIGNIFICANCE AND IMPACT OF THE STUDY: The method should facilitate routine laboratory diagnosis of toxigenic and nontoxigenic C. diphtheriae.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18290809     DOI: 10.1111/j.1472-765X.2007.02310.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  6 in total

1.  Multiplex polymerase chain reaction to identify and determine the toxigenicity of Corynebacterium spp with zoonotic potential and an overview of human and animal infections.

Authors:  Luciene de Fátima Costa Torres; Dayana Ribeiro; Raphael Hirata; Luis Gustavo Carvalho Pacheco; Monica Cristina Souza; Louisy Sanches dos Santos; Cíntia Silva dos Santos; Mohammad Salah; Mateus Matiuzzi da Costa; Marcio Garcia Ribeiro; Salah A Selim; Vasco Ariston de Carvalho Azevedo; Ana Luiza Mattos-Guaraldi
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

2.  Diphtheria outbreak in Maranhão, Brazil: microbiological, clinical and epidemiological aspects.

Authors:  L S Santos; L O Sant'anna; J N Ramos; E M Ladeira; R Stavracakis-Peixoto; L L G Borges; C S Santos; F Napoleão; T C F Camello; G A Pereira; R Hirata; V V Vieira; L M S S Cosme; P S Sabbadini; A L Mattos-Guaraldi
Journal:  Epidemiol Infect       Date:  2015-03       Impact factor: 4.434

3.  The Bacteriology and Its Virulence Factors in Neonatal Infections: Threats to Child Survival Strategies.

Authors:  Obiora Shedrach Ejiofor; Onyinye Mercy Ajunwa; Chijioke Elias Ezeudu; George Ogonna Emechebe; Kenneth Nchekwube Okeke; Christian Chukwuemeka Ifezulike; Ifeoma Mercy Ekejindu; Jude Nnaemeka Okoyeh; Eunice Ogonna Osuala; Angus Nnamdi Oli
Journal:  J Pathog       Date:  2018-07-02

Review 4.  Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976-2020.

Authors:  Giorgio Silva-Santana; Cecília Maria Ferreira Silva; Julianna Giordano Botelho Olivella; Igor Ferreira Silva; Laís Menegoi Oliveira Fernandes; Bruna Ribeiro Sued-Karam; Cíntia Silva Santos; Cassius Souza; Ana Luíza Mattos-Guaraldi
Journal:  Arch Microbiol       Date:  2021-02-24       Impact factor: 2.552

5.  Efficacy of a marine bacterial nuclease against biofilm forming microorganisms isolated from chronic rhinosinusitis.

Authors:  Robert C Shields; Norehan Mokhtar; Michael Ford; Michael J Hall; J Grant Burgess; Mohamed Reda ElBadawey; Nicholas S Jakubovics
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

6.  Clonal multidrug-resistant Corynebacterium striatum within a nosocomial environment, Rio de Janeiro, Brazil.

Authors:  Paulo Victor Pereira Baio; Higor Franceschi Mota; Andréa D'avila Freitas; Débora Leandro Rama Gomes; Juliana Nunes Ramos; Lincoln Oliveira Sant'Anna; Mônica Cristina Souza; Thereza Cristina Ferreira Camello; Raphael Hirata Junior; Verônica Viana Vieira; Ana Luíza Mattos-Guaraldi
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.